- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01412502
Post Traumatic Stress Among Relatives of Brain-dead, Withdrawal of Life Support, and Sudden Death Patients
January 2, 2018 updated by: Centre Hospitalier Universitaire de Nīmes
Evaluation of Post Traumatic Stress Among the Nearest Relatives of Brain-dead, Withdrawal of Life Support, and Sudden Death Patients
This study concerns the nearest relatives of patients who have passed away within 3 days of admission to an ICU due to: (1) brain death with multiple organ donation +/- tissues or (2) death via limitation and / or cessation of active treatment (LATA) without brain death or (3) sudden death of a previously healthy patient (no physical or mental limitations; MacCabe score = 0) within 3 days of admission to ICU without LATA nor brain death.
Our primary objective is to determine the proportion of nearest relatives at risk for post traumatic stress disorder as defined by an Impact of Event Scale score greater than 37, and to compare this factor between the three above-mentioned groups.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
119
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Clichy, France
- Hôpital Beaujon -APHP
-
Marseille, France
- Assistance Publique - Hopitaux de Marseille
-
Montpellier Cedex 05, France, 34295
- CHU Lapeyronie
-
Montpellier cedex 5, France, 34295
- Hôpital Gui De Chauliac (CHU de Montpellier)
-
Nîmes cedex 09, France, 30029
- Centre Hospitalier Universitaire de Nîmes
-
Paris, France
- Hôpital Kremlin Bicêtre - APHP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participants are the nearest relatives (or "person-of-trust") of a patient who has passed away in an intensive care unit (ICU) due to: (1) brain death with multiple organ donation +/- tissues or (2) death via limitation and / or cessation of active treatment (LATA) without brain death or (3) sudden death of a previously healthy patient (no physical or mental limitations; MacCabe score = 0) within 3 days of admission to ICU without LATA nor brain death
Description
Inclusion Criteria:
- Participants are the nearest relatives (or "person-of-trust") of a patient who has passed away in an intensive care unit (ICU). The cause of death must fall into 1 of the following three categories: (1) brain death with multiple organ donation +/- tissues; (2) death via limitation and / or cessation of active treatment (LATA) without brain death; (3) sudden death of a previously healthy patient (no physical or mental limitations; MacCabe score = 0) within 3 days of admission to ICU without LATA nor brain death
- The participant must be one of the following (roman numerals indicate prioritization in choice of participants, if needed): (i) designated "person-of-trust"; (ii) spouse/partner of the deceased; (iii) parent of the deceased; (iv) child of the deceased; (v) sibling of the deceased.
Exclusion Criteria:
- Patient deceased after 3 days of ICU care without LATA
- The deceased was under 18 years old
- The deceased was over 70 years old
- Refusal to participated
- Participant does not speak French
- The participant is under judicial protection, under tutorship or curatorship
- The participant is deaf or mute
- The deceased has no nearest relative
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Brain death with organ donation
Participants in this group are the nearest relatives (or "person-of-trust") of a patient who has passed away within 3 days of admission to an intensive care unit.
The cause of death includes brain death with multiple organ donation +/- tissues.
|
The Impact of Event Scale and Hospital Depression and Anxiety Score questionnaires are administered to participants.
|
Limitation/cessation of active treatment
Participants in this group are the nearest relatives (or "person-of-trust") of a patient who has passed away within 3 days of admission to an intensive care unit.
The cause of death includes limitation/cessation of active treatment without brain death.
|
The Impact of Event Scale and Hospital Depression and Anxiety Score questionnaires are administered to participants.
|
Sudden death
Participants in this group are the nearest relatives (or "person-of-trust") of a patient who has passed away within 3 days of admission to an intensive care unit.
The cause of death was sudden death of a previously healthy patient (no physical or mental limitations; MacCabe score = 0) within 3 days of admission to ICU without LATA nor brain death.
|
The Impact of Event Scale and Hospital Depression and Anxiety Score questionnaires are administered to participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IES-R > 37: yes/no
Time Frame: 6 weeks
|
Impact of Event Scale score greater than 37: yes/no
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IES-R
Time Frame: 6 weeks
|
Impact of Event scale score (score varying from 0 (no risk of post traumatic stress) to 88 (highest risk of post traumatic stress)).
|
6 weeks
|
HDAS score
Time Frame: 6 weeks
|
Hospital Depression and Anxiety Score (varies from 0 to 21).
A score >8 indicates clinically significant anxiety/depression.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Jean Yves Lefrant, MD PhD, Centre Hospitalier Universitaire de Nîmes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 15, 2012
Primary Completion (ACTUAL)
June 28, 2016
Study Completion (ACTUAL)
June 28, 2016
Study Registration Dates
First Submitted
August 8, 2011
First Submitted That Met QC Criteria
August 8, 2011
First Posted (ESTIMATE)
August 9, 2011
Study Record Updates
Last Update Posted (ACTUAL)
January 3, 2018
Last Update Submitted That Met QC Criteria
January 2, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Trauma and Stressor Related Disorders
- Death
- Unconsciousness
- Consciousness Disorders
- Coma
- Stress Disorders, Traumatic
- Stress Disorders, Post-Traumatic
- Brain Death
- Death, Sudden
Other Study ID Numbers
- PHRC-N/2009/CB-01
- 2009-A00848-49 (OTHER: RCB number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Disorders, Post-Traumatic
-
University of California, Los AngelesDefense Advanced Research Projects Agency; Defense Group, Inc.CompletedPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder, ChronicUnited States
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH); Oregon Clinical...CompletedPost-Traumatic Stress DisordersUnited States
-
US Department of Veterans AffairsEmory UniversityWithdrawnPost-Traumatic Stress Disorders
-
University of KonstanzGerman Research Foundation; NGO vivo e.V.; GTZ-German Technical Cooperation,... and other collaboratorsCompletedPost-Traumatic Stress DisordersSri Lanka
-
Weill Medical College of Cornell UniversityCompletedPost-traumatic Stress Disorder | Complex Post-Traumatic Stress DisorderUnited States
-
University of California, Los AngelesRecruitingPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder in ChildrenUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPost-Traumatic Stress Disorder in Children | Post-Traumatic Stress Disorder in AdolescenceUnited States
-
Erkin Oğuz SARINot yet recruitingPost-Traumatic Stress DisorderTurkey
-
University Hospital, LilleNot yet recruiting
-
Steinn SteingrimssonRecruiting
Clinical Trials on IES-R and HDAS scores
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
University of ChicagoActive, not recruitingCovid-19 | Critical Illness | Respiratory Failure | Corona Virus InfectionUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingEndometrial CancerUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Mahidol UniversityUnknownLearning Development
-
University Hospital, Clermont-FerrandUnknownPostpartum Depression | Postpartum Hemorrhage | Postpartum Women | Postpartum Stress | Postpartum AnxietyFrance
-
Hospices Civils de LyonTerminatedMood Disorders | Anxiety | Post Traumatic Stress DisorderFrance
-
CHU de Quebec-Universite LavalRecruitingProstate Cancer | Localized Prostate Carcinoma | Radiotherapy Side Effect | Radiotherapy | Brachytherapy | HypofractionationCanada
-
Kanuni Sultan Suleyman Training and Research HospitalActive, not recruiting
-
Acibadem Fulya HastanesiCompleted